Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.
作者信息
Klemm Per, Hancock Viktoria, Schembri Mark A
机构信息
Microbial Adhesion Group, Center for Biomedical Microbiology, BioCentrum-DTU, Technical University of Denmark, DK-2800 Lyngby, Denmark.
出版信息
Infect Immun. 2007 Aug;75(8):3688-95. doi: 10.1128/IAI.01730-06. Epub 2007 May 14.
Abstract
摘要
相似文献
1
Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.渐趋平和：大肠杆菌无症状菌尿菌株83972对共生状态的适应
Infect Immun. 2007 Aug;75(8):3688-95. doi: 10.1128/IAI.01730-06. Epub 2007 May 14.
2
Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes.比较健康个体与医院患者无症状菌尿大肠埃希菌分离株发现，长期膀胱定殖选择了毒力减弱的表型。
Infect Immun. 2012 Feb;80(2):668-78. doi: 10.1128/IAI.06191-11. Epub 2011 Nov 21.
3
Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy.引起孕妇无症状菌尿的大肠埃希菌菌株的毒力潜力。
J Clin Microbiol. 2011 Nov;49(11):3950-3. doi: 10.1128/JCM.00892-11. Epub 2011 Sep 14.
4
Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.大肠杆菌无症状菌尿菌株83972的分子特征：病原菌的驯化
Infect Immun. 2006 Jan;74(1):781-5. doi: 10.1128/IAI.74.1.781-785.2006.
5
Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?泌尿道共生的分子基础：低毒力还是毒力衰减？
Infect Immun. 2008 Feb;76(2):695-703. doi: 10.1128/IAI.01215-07. Epub 2007 Nov 26.
6
Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles.与单纯性和复杂性膀胱炎及无症状菌尿症相关的大肠杆菌分离株具有相似的系统发育、毒力基因和O血清群谱。
J Clin Microbiol. 2006 Dec;44(12):4589-92. doi: 10.1128/JCM.02070-06. Epub 2006 Oct 25.
7
Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital.患者特征而非毒力因子可区分医院无症状和有症状大肠埃希菌菌尿症。
BMC Infect Dis. 2013 May 10;13:213. doi: 10.1186/1471-2334-13-213.
8
Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.无症状菌尿大肠杆菌菌株VR50的分子分析显示，通过基因获取适应泌尿道。
Infect Immun. 2015 May;83(5):1749-64. doi: 10.1128/IAI.02810-14. Epub 2015 Feb 9.
9
Virulence versus fitness determinants in Escherichia coli isolated from asymptomatic bacteriuria in healthy nonpregnant women.从健康未孕女性无症状菌尿中分离出的大肠杆菌的毒力与适应性决定因素
Indian J Med Microbiol. 2016 Jan-Mar;34(1):46-51. doi: 10.4103/0255-0857.174103.
引用本文的文献
1
Bacterial adhesion strategies and countermeasures in urinary tract infection.尿路感染中的细菌黏附策略与应对措施
Nat Microbiol. 2025 Mar;10(3):627-645. doi: 10.1038/s41564-025-01926-8. Epub 2025 Feb 10.
2
dry surface biofilm: morphology, single-cell landscape, and sanitization.干燥表面生物膜：形态、单细胞景观和消毒。
Appl Environ Microbiol. 2024 Nov 20;90(11):e0162324. doi: 10.1128/aem.01623-24. Epub 2024 Nov 4.
3
Genotypic and phenotypic characterisation of asymptomatic bacteriuria (ABU) isolates displaying bacterial interference against multi-drug resistant uropathogenic E. Coli.无症状菌尿（ABU）分离株的基因型和表型特征，这些分离株对多药耐药尿路致病性大肠杆菌表现出细菌干扰作用。
Arch Microbiol. 2024 Sep 9;206(10):394. doi: 10.1007/s00203-024-04114-0.
4
Competitive fitness of asymptomatic bacteriuria strain 83972 against uropathogens in human urine.无症状菌尿株 83972 对人尿液中尿病原体的竞争适应性。
Infect Immun. 2024 Jun 11;92(6):e0017324. doi: 10.1128/iai.00173-24. Epub 2024 May 23.
5
A human urothelial microtissue model reveals shared colonization and survival strategies between uropathogens and commensals.一种人尿路上皮微组织模型揭示了尿路病原体和共生菌之间的共同定植和生存策略。
Sci Adv. 2023 Nov 10;9(45):eadi9834. doi: 10.1126/sciadv.adi9834. Epub 2023 Nov 8.
6
Genomic Epidemiology and Evolution of in Wild Animals in Mexico.在墨西哥野生动物中 的基因组流行病学和进化。
mSphere. 2021 Jan 6;6(1):e00738-20. doi: 10.1128/mSphere.00738-20.
7
Metabolomics Study on Pathogenic and Non-pathogenic . with Closely Related Genomes with a Focus on Yersiniabactin and Its Known and Novel Derivatives.对具有密切相关基因组的致病性和非致病性……进行代谢组学研究，重点关注耶尔森菌素及其已知和新型衍生物。
Metabolites. 2020 May 28;10(6):221. doi: 10.3390/metabo10060221.
8
Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices.用于预防和治疗医疗器械上生物膜相关感染的最新纳米技术方法。
Biomed Res Int. 2016;2016:1851242. doi: 10.1155/2016/1851242. Epub 2016 Oct 31.
9
The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine.菌尿症基础：微生物在尿液中持续存在的策略
Front Cell Infect Microbiol. 2016 Feb 8;6:14. doi: 10.3389/fcimb.2016.00014. eCollection 2016.
10
The emerging threat of multidrug-resistant Gram-negative bacteria in urology.泌尿外科学中出现的多重耐药革兰氏阴性菌的新威胁。
Nat Rev Urol. 2015 Oct;12(10):570-84. doi: 10.1038/nrurol.2015.199. Epub 2015 Sep 1.
本文引用的文献
1
Type 1 Fimbriae, Curli, and Antigen 43: Adhesion, Colonization, and Biofilm Formation.1型菌毛、卷曲菌毛和抗原43：黏附、定植与生物膜形成
EcoSal Plus. 2004 Dec;1(1). doi: 10.1128/ecosalplus.8.3.2.6.
2
Biofilm exclusion of uropathogenic bacteria by selected asymptomatic bacteriuria Escherichia coli strains.选定的无症状菌尿大肠杆菌菌株对尿路致病性细菌的生物膜排斥作用
Microbiology (Reading). 2007 Jun;153(Pt 6):1711-1719. doi: 10.1099/mic.0.2006/004721-0.
3
Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens.黑洞、抗毒力基因与细菌病原体进化中的基因失活
FEMS Microbiol Lett. 2007 Feb;267(1):1-8. doi: 10.1111/j.1574-6968.2006.00526.x.
4
Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains.无症状且具有致病性的尿路感染大肠杆菌菌株的生物膜形成
FEMS Microbiol Lett. 2007 Feb;267(1):30-7. doi: 10.1111/j.1574-6968.2006.00507.x. Epub 2006 Dec 8.
5
Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urine.人尿中生物膜生长期间无症状菌尿大肠杆菌的全基因组表达谱分析
Infect Immun. 2007 Feb;75(2):966-76. doi: 10.1128/IAI.01748-06. Epub 2006 Dec 4.
6
Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.生物膜形成在尿路致病性大肠杆菌引起的尿路感染持续存在中的作用。
Clin Microbiol Infect. 2006 Oct;12(10):1034-6. doi: 10.1111/j.1469-0691.2006.01543.x.
7
Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition.无症状菌尿大肠杆菌菌株：黏附素、生长与竞争
FEMS Microbiol Lett. 2006 Sep;262(1):22-30. doi: 10.1111/j.1574-6968.2006.00355.x.
8
Bacterial interference--is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?细菌干扰——用大肠杆菌83972进行蓄意定植是否是复发性尿路感染患者的一种替代治疗方法？
Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S26-9. doi: 10.1016/j.ijantimicag.2006.05.007. Epub 2006 Jul 14.
9
Asymptomatic bacteriuria: review and discussion of the IDSA guidelines.无症状菌尿：美国感染病学会指南的综述与讨论
Int J Antimicrob Agents. 2006 Aug;28 Suppl 1:S42-8. doi: 10.1016/j.ijantimicag.2006.05.010. Epub 2006 Jul 10.
10
Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae.无症状菌尿大肠杆菌菌株83972在foc位点携带突变，无法表达F1C菌毛。
Microbiology (Reading). 2006 Jun;152(Pt 6):1799-1806. doi: 10.1099/mic.0.28711-0.
Zotero 插件